You may print, copy, and/or redistribute the content, without modification, for your own non-commercial use. All content, images, and text are the property of Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). No content, images, or text may be modified or otherwise altered in any manner without the express written permission of BIPI.
On occasion, certain materials may be retired from the site. Retired pieces will be replaced with updated and/or similar pieces as often as possible.
Many of the materials in the Solutions Center can be personalized with your health system's logo. In the Solutions Center, look for materials with the button, "Personalize with logo." Then, follow the simple steps to get started.
Revisit the Strategies for Quality Care website to see the latest information. The Home page will be updated with new and featured content.
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance that centers on compounds representing several of the largest diabetes treatment classes. Depending on geographies, the companies either co-promote or separately promote the respective molecules each contributing to the alliance. The Alliance leverages the strengths of two of the world’s leading pharmaceutical companies to focus on patient needs. By joining forces, the companies demonstrate their commitment, not only to the care of people with diabetes, but also to investigating the potential to address areas of unmet medical need.
Strategies for Quality Care is updated frequently. Due to the rapidly changing nature of the healthcare landscape, information on the website may become outdated. Resources that are outdated will periodically be removed from the website as appropriate. Users of this website are responsible for independently verifying any and all information and ongoing validation or resources that were previously downloaded.